Interferon-α differentially affects homeostasis of human plasmacytoid and myeloid dendritic cells

Journal of Interferon and Cytokine Research

Volumn 29, Issue 3, 2009, Pages 145-159

  Cicinnati, Vito R ^a   Kang, Jinyu ^a   Hou, Jing ^a   Lindemann, Monika ^a   Koop, Karsten ^a   Tüting, Thomas ^b   Gerken, Guido ^a   Beckebaum, Susanne ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL11 CHEMOKINE; GROWTH FACTOR; INTERCELLULAR ADHESION MOLECULE 1; L SELECTIN; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; RECOMBINANT ALPHA INTERFERON; STROMAL CELL DERIVED FACTOR 1; ALPHA INTERFERON; CHEMOKINE RECEPTOR; IMMUNOLOGIC FACTOR;

ADULT; ARTICLE; CELL COUNT; CELL CULTURE; CELL MIGRATION; CELL VIABILITY; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; FLOW CYTOMETRY; HOMEOSTASIS; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOSTIMULATION; INTERFERON PRODUCTION; LYMPH NODE; MALE; MIXED LYMPHOCYTE REACTION; MONONUCLEAR CELL; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANALYSIS OF VARIANCE; BONE MARROW CELL; CELL MOTION; CELL PROLIFERATION; CHEMOTAXIS; CYTOLOGY; DRUG EFFECTS; ENDOCYTOSIS; IMMUNOLOGY; IMMUNOPHENOTYPING; METABOLISM; MIDDLE AGED; MIXED LYMPHOCYTE CULTURE; T LYMPHOCYTE;

ANALYSIS OF VARIANCE; CELL COUNT; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CHEMOTAXIS; DENDRITIC CELLS; ENDOCYTOSIS; FEMALE; FLOW CYTOMETRY; HOMEOSTASIS; HUMANS; IMMUNOLOGIC FACTORS; IMMUNOPHENOTYPING; INTERFERON-ALPHA; LYMPHOCYTE CULTURE TEST, MIXED; MALE; MIDDLE AGED; MYELOID CELLS; RECEPTORS, CHEMOKINE; T-LYMPHOCYTES;

EID: 61749097912     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2008.0011     Document Type: Article

References (66)

1. Aliberti J, Schulz O, Pennington DJ, Tsujimura H, Reis e Sousa, Ozato K, Sher A. 2003. Essential role for ICSBP in the in vivo development of murine CD8alpha + dendritic cells. Blood 101(1):305-310.
2. Asselin-Paturel C, Brizard G, Chemin K, Boonstra A, O'Garra A, Vicari A, Trinchieri G. 2005. Type I interferon dependence of plasmacytoid dendritic cell activation and migration. J Exp Med 201(7):1157-1167.
3. Avraamides G, Ng CY, David R, Gu Y, Fazekasova H, Mirenda V, Foster GR, Runkel L, Lombardi G, Marelli-Berg FM. 2007. IFN-alpha2 induces leukocyte integrin redistribution, increased adhesion, and migration. J Interferon Cytokine Res 27(4):291-303.
4. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K. 2000. Immunobiology of dendritic cells. Annu Rev Immunol 18:767-811.
5. Barratt-Boyes SM, Thomson AW. 2005. Dendritic cells: tools and targets for transplant tolerance. Am J Transplant 5(12):2807-2813.
6. Beckebaum S, Cicinnati VR, Zhang X, Ferencik S, Frilling A, Grosse-Wilde H, Broelsch CE, Gerken G. 2003. Hepatitis B virus-induced defect of monocyte-derived dendritic cells leads to impaired T helper type 1 response in vitro: mechanisms for viral immune escape. Immunology 109(4):487-495.
7. Beckebaum S, Zhang X, Chen X, Yu Z, Frilling A, Dworacki G, Grosse-Wilde H, Broelsch CE, Gerken G, Cicinnati VR. 2004. Increased levels of interleukin-10 in serum from patients with hepatocellular carcinoma correlate with profound numerical deficiencies and immature phenotype of circulating dendritic cell subsets. Clin Cancer Res 10(21):7260-7269.
8. Bekisz J, Schmeisser H, Hernandez J, Goldman ND, Zoon KC. 2004. Human interferons alpha, beta and omega. Growth Factors 22(4):243-251.
9. Blom B, Ho S, Antonenko S, Liu YJ. 2000. Generation of interferon alpha-producing predendritic cell (Pre-DC)2 from human CD34(+) hematopoietic stem cells. J Exp Med 192(12):1785-1796.
10. Branca AA. 1988. Interferon receptors. In Vitro Cell Dev Biol 24(3):155-165.
11. Cella M, Facchetti F, Lanzavecchia A, Colonna M. 2000. Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. Nat Immunol 1(4):305-310.
12. Cella M, Jarrossay D, Facchetti F, Alebardi O, Nakajima H, Lanzavecchia A, Colonna M. 1999. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med 5(8):919-923.
13. Colonna L, Dinnall JA, Shivers DK, Frisoni L, Caricchio R, Gallucci S. 2006. Abnormal costimulatory phenotype and function of dendritic cells before and after the onset of severe murine lupus. Arthritis Res Ther 8(2):R49.
14. Colonna M, Trinchieri G, Liu YJ. 2004. Plasmacytoid dendritic cells in immunity. Nat Immunol 5(12):1219-1226.
15. Comeau MR, Van der Vuurst de Vries AR, Maliszewski CR, Galibert L. 2002. CD123bright plasmacytoid predendritic cells: progenitors undergoing cell fate conversion? J Immunol 169(1): 75-83.
16. Curiel TJ, Wei S, Dong H, Alvarez X, Cheng P, Mottram P, Krzysiek R, Knutson KL, Daniel B, Zimmermann MC, David O, Burow M, Gordon A, Dhurandhar N, Myers L, Berggren R, Hemminki A, Alvarez RD, Emilie D, Curiel DT, Chen L, Zou W. 2003. Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity. Nat Med 9(5):562-567.
17. Dauer M, Pohl K, Obermaier B, Meskendahl T, Robe J, Schnurr M, Endres S, Eigler A. 2003. Interferon-alpha disables dendritic cell precursors: dendritic cells derived from interferon-alpha-treated monocytes are defective in maturation and T-cell stimulation. Immunology 110(1):38-47.
18. Dauer M, Schad K, Junkmann J, Bauer C, Herten J, Kiefl R, Schnurr M, Endres S, Eigler A. 2006. IFN-alpha promotes definitive maturation of dendritic cells generated by short-term culture of monocytes with GM-CSF and IL-4. J Leukoc Biol 80(2):278-286.
19. Diacovo TG, Blasius AL, Mak TW, Cella M, Colonna M. 2005. Adhesive mechanisms governing interferon-producing cell recruitment into lymph nodes. J Exp Med 202(5):687-696.
20. Dieu MC, Vanbervliet B, Vicari A, Bridon JM, Oldham E, it-Yahia S, Briere F, Zlotnik A, Lebecque S, Caux C. 1998. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J Exp Med 188(2):373-386.
21. Dzionek A, Fuchs A, Schmidt P, Cremer S, Zysk M, Miltenyi S, Buck DW, Schmitz J. 2000. BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol 165(11):6037-6046.
22. Dzionek A, Inagaki Y, Okawa K, Nagafune J, Rock J, Sohma Y, Winkels G, Zysk M, Yamaguchi Y, Schmitz J. 2002. Plasmacytoid dendritic cells: from specific surface markers to specific cellular functions. Hum Immunol 63(12):1133-1148.
23. Fallarino F, Asselin-Paturel C, Vacca C, Bianchi R, Gizzi S, Fioretti MC, Trinchieri G, Grohmann U, Puccetti P. 2004. Murine plasmacytoid dendritic cells initiate the immunosuppressive pathway of tryptophan catabolism in response to CD200 receptor engagement. J Immunol 173(6):3748-3754.
24. Fanning SL, George TC, Feng D, Feldman SB, Megjugorac NJ, Izaguirre AG, Fitzgerald-Bocarsly P. 2006. Receptor cross-linking on human plasmacytoid dendritic cells leads to the regulation of IFN-alpha production. J Immunol 177(9):5829-5839.
25. Funauchi M, Yoo BS, Nozaki Y, Sugiyama M, Ohno M, Kinoshita K, Kanamaru A. 2002. Dysregulation of the granulocyte-macrophage colony-stimulating factor receptor is one of the causes of defective expression of CD80 antigen in systemic lupus erythematosus. Lupus 11(5):317-321.
26. Garcia-Cozar FJ, Molina IJ, Cuadrado MJ, Marubayashi M, Pena J, Santamaria M. 1996. Defective B7 expression on antigen-presenting cells underlying T cell activation abnormalities in systemic lupus erythematosus (SLE) patients. Clin Exp Immunol 104(1):72-79.
27. Gunn MD. 2003. Chemokine mediated control of dendritic cell migration and function. Semin Immunol 15(5):271-276.
28. Hilkens CM, Schlaak JF, Kerr IM. 2003. Differential responses to IFN-alpha subtypes in human T cells and dendritic cells. J Immunol 171(10):5255-5263.
29. Ho CS, Munster D, Pyke CM, Hart DN, Lopez JA. 2002. Spontaneous generation and survival of blood dendritic cells in mononuclear cell culture without exogenous cytokines. Blood 99(8):2897-2904.
30. Honda K, Mizutani T, Taniguchi T. 2004. Negative regulation of IFN-alpha/beta signaling by IFN regulatory factor 2 for homeostatic development of dendritic cells. Proc Natl Acad Sci USA 101(8):2416-2421.
31. Ito T, Amakawa R, Inaba M, Ikehara S, Inaba K, Fukuhara S. 2001. Differential regulation of human blood dendritic cell subsets by IFNs. J Immunol 166(5):2961-2969.
32. Kadowaki N, Antonenko S, Lau JY, Liu YJ. 2000. Natural interferon alpha/beta-producing cells link innate and adaptive immunity. J Exp Med 192(2):219-226.
33. Krug A, Uppaluri R, Facchetti F, Dorner BG, Sheehan KC, Schreiber RD, Cella M, Colonna M. 2002. IFN-producing cells respond to CXCR3 ligands in the presence of CXCL12 and secrete inflammatory chemokines upon activation. J Immunol 169(11):6079-6083.
34. Larner AC, Petricoin EF, Nakagawa Y, Finbloom DS. 1993. IL-4 attenuates the transcriptional activation of both IFN-alpha and IFN-gamma-induced cellular gene expression in monocytes and monocytic cell lines. J Immunol 150(5):1944-1950.
35. Lehner M, Felzmann T, Clodi K, Holter W. 2001. Type I interferons in combination with bacterial stimuli induce apoptosis of monocyte-derived dendritic cells. Blood 98(3):736-742.
36. Luft T, Pang KC, Thomas E, Hertzog P, Hart DN, Trapani J, Cebon J. 1998. Type I IFNs enhance the terminal differentiation of dendritic cells. J Immunol 161(4):1947-1953.
37. Mailliard RB, Wankowicz-Kalinska A, Cai Q, Wesa A, Hilkens CM, Kapsenberg ML, Kirkwood JM, Storkus WJ, Kalinski P. 2004. Alpha-type-1 polarized dendritic cells: a novel immunization tool with optimized CTL-inducing activity. Cancer Res 64(17):5934-5937.
38. McRae BL, Nagai T, Semnani RT, van Seventer JM, van Seventer GA. 2000. Interferon-alpha and -beta inhibit the in vitro differentiation of immunocompetent human dendritic cells from CD14(+) precursors. Blood 96(1):210-217.
39. McRae BL, Semnani RT, Hayes MP, van Seventer GA. 1998. Type I IFNs inhibit human dendritic cell IL-12 production and Th1 cell development. J Immunol 160(9):4298-4304.
40. Mohty M, Vialle-Castellano A, Nunes JA, Isnardon D, Olive D, Gaugler B. 2003. IFN-alpha skews monocyte differentiation into Toll-like receptor 7-expressing dendritic cells with potent functional activities. J Immunol 171(7):3385-3393.
41. Ochando JC, Homma C, Yang Y, Hidalgo A, Garin A, Tacke F, Angeli V, Li Y, Boros P, Ding Y, Jessberger R, Trinchieri G, Lira SA, Randolph GJ, Bromberg JS. 2006. Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts. Nat Immunol 7(6):652-662.
42. Padovan E, Spagnoli GC, Ferrantini M, Heberer M. 2002. IFN-alpha2a induces IP-10/CXCL10 and MIG/CXCL9 production in monocyte-derived dendritic cells and enhances their capacity to attract and stimulate CD8+ effector T cells. J Leukoc Biol 71(4):669-676.
43. Paquette RL, Hsu NC, Kiertscher SM, Park AN, Tran L, Roth MD, Glaspy JA. 1998. Interferon-alpha and granulocyte-macrophage colony-stimulating factor differentiate peripheral blood monocytes into potent antigen-presenting cells. J Leukoc Biol 64(3): 358-367.
44. Parlato S, Santini SM, Lapenta C, Di PT, Logozzi M, Spada M, Giammarioli AM, Malorni W, Fais S, Belardelli F. 2001. Expression of CCR-7, MIP-3beta, and Th-1 chemokines in type I IFN-induced monocyte-derived dendritic cells: importance for the rapid acquisition of potent migratory and functional activities. Blood 98(10):3022-3029.
45. Penna G, Sozzani S, Adorini L. 2001. Cutting edge: selective usage of chemokine receptors by plasmacytoid dendritic cells. J Immunol 167(4):1862-1866.
46. Penna G, Vulcano M, Sozzani S, Adorini L. 2002. Differential migration behavior and chemokine production by myeloid and plasmacytoid dendritic cells. Hum Immunol 63(12):1164-1171.
47. Platanias LC. 2005. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol 5(5):375-386.
48. Radvanyi LG, Banerjee A, Weir M, Messner H. 1999. Low levels of interferon-alpha induce CD86 (B7.2) expression and accelerates dendritic cell maturation from human peripheral blood mononuclear cells. Scand J Immunol 50(5):499-509.
49. Robert C, Fuhlbrigge RC, Kieffer JD, Ayehunie S, Hynes RO, Cheng G, Grabbe S, von Andrian UH, Kupper TS. 1999. Interaction of dendritic cells with skin endothelium: A new perspective on immunosurveillance. J Exp Med 189(4):627-636.
50. Sallusto F, Schaerli P, Loetscher P, Schaniel C, Lenig D, Mackay CR, Qin S, Lanzavecchia A. 1998. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur J Immunol 28(9):2760-2769.
51. Santini SM, Di PT, Lapenta C, Parlato S, Logozzi M, Belardelli F. 2003. A new type I IFN-mediated pathway for the rapid differentiation of monocytes into highly active dendritic cells. Stem Cells 21(3):357-362.
52. Santini SM, Lapenta C, Logozzi M, Parlato S, Spada M, Di PT, Belardelli F. 2000. Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice. J Exp Med 191(10):1777-1788.
53. Scheinecker C, Zwolfer B, Koller M, Manner G, Smolen JS. 2001. Alterations of dendritic cells in systemic lupus erythematosus: phenotypic and functional deficiencies. Arthritis Rheum 44(4):856-865.
54. Schiavoni G, Mattei F, Borghi P, Sestili P, Venditti M, Morse HC, III, Belardelli F, Gabriele L. 2004. ICSBP is critically involved in the normal development and trafficking of Langerhans cells and dermal dendritic cells. Blood 103(6):2221-2228.
55. Schiavoni G, Mattei F, Sestili P, Borghi P, Venditti M, Morse HC, III, Belardelli F, Gabriele L. 2002. ICSBP is essential for the development of mouse type I interferon-producing cells and for the generation and activation of CD8alpha(+) dendritic cells. J Exp Med 196(11):1415-1425.
56. Schlaak JF, Hilkens CM, Costa-Pereira AP, Strobl B, Aberger F, Frischauf AM, Kerr IM. 2002. Cell-type and donor-specific transcriptional responses to interferon-alpha. Use of customized gene arrays. J Biol Chem 277(51):49428-49437.
57. Schreiner B, Mitsdoerffer M, Kieseier BC, Chen L, Hartung HP, Weller M, Wiendl H. 2004. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis. J Neuroimmunol 155(1-2):172-182.
58. Siegal FP, Kadowaki N, Shodell M, Fitzgerald-Bocarsly PA, Shah K, Ho S, Antonenko S, Liu YJ. 1999. The nature of the principal type 1 interferon-producing cells in human blood. Science 284(5421):1835-1837.
59. Sozzani S, Allavena P, D'Amico G, Luini W, Bianchi G, Kataura M, Imai T, Yoshie O, Bonecchi R, Mantovani A. 1998. Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. J Immunol 161(3):1083-1086.
60. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD. 1998. How cells respond to interferons. Annu Rev Biochem 67:227-264.
61. Tamura T, Tailor P, Yamaoka K, Kong HJ, Tsujimura H, O'Shea JJ, Singh H, Ozato K. 2005. IFN regulatory factor-4 and -8 govern dendritic cell subset development and their functional diversity. J Immunol 174(5):2573-2581.
62. Tough DF. 2004. Type I interferon as a link between innate and adaptive immunity through dendritic cell stimulation. Leuk Lymphoma 45(2):257-264.
63. Tsujimura H, Tamura T, Ozato K. 2003. Cutting edge: IFN consensus sequence binding protein/IFN regulatory factor 8 drives the development of type I IFN-producing plasmacytoid dendritic cells. J Immunol 170(3):1131-1135.
64. Vanbervliet B, driss-Vermare N, Massacrier C, Homey B, de BO, Briere F, Trinchieri G, Caux C. 2003. The inducible CXCR3 ligands control plasmacytoid dendritic cell responsiveness to the constitutive chemokine stromal cell-derived factor 1 (SDF-1)/CXCL12. J Exp Med 198(5):823-830.
65. Verma A, Deb DK, Sassano A, Uddin S, Varga J, Wickrema A, Platanias LC. 2002. Activation of the p38 mitogen-activated protein kinase mediates the suppressive effects of type I interferons and transforming growth factor-beta on normal hematopoiesis. J Biol Chem 277(10):7726-7735.
66. Yoneyama H, Matsuno K, Zhang Y, Nishiwaki T, Kitabatake M, Ueha S, Narumi S, Morikawa S, Ezaki T, Lu B, Gerard C, Ishikawa S, Matsushima K. 2004. Evidence for recruitment of plasmacytoid dendritic cell precursors to inflamed lymph nodes through high endothelial venules. Int Immunol 16(7):915-928.